Latest News about MRK
Recent news which mentions MRK
OPKO Health's Cancer & Infectious Disease Focused Subsidiary Inks Vaccine Development Pact With Merck
March 08, 2023
From Benzinga
2 Top Healthcare Stocks to Buy Right Now
March 08, 2023
From Motley Fool
Health Care ETFs Have Lost In The Last Month - These Top Pharma Stocks Are The Reason
March 07, 2023
From Benzinga
From MarketWatch
Analyst Downgrades Gossamer Bio As Merck's Sotatercept Might Overshadow Seralutinib's Success
March 07, 2023
From Benzinga
From Benzinga
From Benzinga
After Shelving Two Keytruda Trials, Merck Touts Encouraging Data From Keytuda Regime Study In Lung Cancer Patients
March 01, 2023
Tickers
MRK
From Benzinga
Why Compugen Shares Are Up Today
February 28, 2023
From Motley Fool
Merck Discontinues Two Keytruda Combo Therapy Trials In Prostate & Lung Cancer Settings
February 28, 2023
Tickers
MRK
From Benzinga
The 20 worst U.S. stocks in February: the biggest loser dropped 36%
February 28, 2023
From MarketWatch
Analyst Cautions Investors On Overreacting To 'Early-Stage' Pfizer/Seagen Discussions
February 27, 2023
From Benzinga
Seagen Stock Soars On Pfizer Takeover Talks: What's Going On?
February 27, 2023
From Benzinga
From MarketWatch
Pfizer In Early Talks To Buy Cancer-Focused Seagen: WSJ
February 26, 2023
From Benzinga
US Senators Warren, Sanders Urge 'Close Scrutiny' On Merck's Keytruda-Related Patents
February 24, 2023
Tickers
MRK
From Benzinga
WHO panel is reviewing whether COVID vaccines need updating, as agency monitors 7 omicron subvariants
February 24, 2023
From MarketWatch
European Authority Recommends Against Approval For Merck-Ridgeback Biotherapeutics' COVID-19 Pill
February 24, 2023
Tickers
MRK
From Benzinga
Moderna’s stock slides as earnings fall short of estimates amid steep decline in COVID-vaccine sales
February 23, 2023
From MarketWatch
From Benzinga
Intel’s dividend cut shows the need for quality. Here are 20 dividend stocks screened by UBS.
February 22, 2023
From MarketWatch
Benzinga's Top Ratings Upgrades, Downgrades For February 22, 2023
February 22, 2023
From Benzinga
This Recession-Proof Company Has a Best-in-Class Dividend
February 22, 2023
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.